Fund Description
ProShares UltraShort Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the inverse (opposite) of the daily performance of the NASDAQ Biotechnology Index.
Fund Profile
Fund Name ProShares UltraShort Nasdaq Biotechnology
Fund Exchange Ticker BIS
Fund Sponsor ProShares
Fund ISIN US74347G8380
Net Expense Ratio 0.95 %
Fund Inception Date 7 April 2010
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Equity - Leveraged / Inverse
Asset Class Equities (Stocks)
Index Linked Passive
Index Name NASDAQ Biotechnology Index
Index Provider Nasdaq
Currency Hedged No
Inverse / Leveraged Inverse (-2x)
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 1 December 2023
Asset Under Management 4.45 Million (USD)
1 Month Total Return -6.43 %
Year To Date Return 15.63 %
1 Year Total Return -9.77 %
3 Year Annualized Total Return -7.86 %
NAV 22.6684
Share Outstanding 196,100
Top 10 Holdings (Invalid date)
Constituent Name Constituent Ticker Constituent Type Weighting